Literature DB >> 28554415

Treatment of Nonmotor Symptoms in Parkinson's Disease.

Anna Sauerbier1, Ilaria Cova2, Miguel Rosa-Grilo3, Raquel N Taddei3, Laurie K Mischley4, K Ray Chaudhuri5.   

Abstract

Nonmotor symptoms (NMS) are integral to Parkinson's disease (PD) and the management can often be challenging. In spite of the growing evidence that NMS have a key impact on the quality of life of patients and caregivers, most clinical trials still focus on motor symptoms as primary outcomes. As a consequence strong evidence-based treatment recommendations for NMS occurring in PD are spare. In this chapter, the current data addressing the treatment of major NMS such as sleep, cognitive and autonomic dysfunction, and depression and anxiety are described.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nonmotor symptoms; Parkinson's disease; Treatment

Mesh:

Year:  2017        PMID: 28554415     DOI: 10.1016/bs.irn.2017.03.002

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  3 in total

1.  Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson's Animal Model.

Authors:  Se Jong Oh; Heesu Ahn; Ki-Hye Jung; Sang Jin Han; Kyung Rok Nam; Kyung Jun Kang; Ji-Ae Park; Kyo Chul Lee; Yong Jin Lee; Jae Yong Choi
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

2.  Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS.

Authors:  Carmen Rodriguez-Blazquez; Anette Schrag; Alexandra Rizos; K Ray Chaudhuri; Pablo Martinez-Martin; Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2020-12-21

3.  Training Neurodegenerative Disease Support Group Leaders: A New Support Group Functioning Scale.

Authors:  Therese V Cash; Christopher Kilbourn; Sarah K Lageman
Journal:  Gerontol Geriatr Med       Date:  2018-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.